NCT04120649 Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma Status COMPLETED Phase N/A
NCT04104776 A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas Status RECRUITING Phase PHASE1/PHASE2
NCT04080284 Trial of Maintenance With Niraparib- Uterine Serous Carcinoma Status COMPLETED Phase PHASE2
NCT04073680 A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors Status UNKNOWN Phase PHASE1/PHASE2
NCT04068675 Effects of Centering Pre-operative Counseling on Patient Reported Anxiety Status COMPLETED Phase NA
NCT04044859 ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04021459 Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery. Status COMPLETED Phase NA
NCT04010487 Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis Status UNKNOWN Phase N/A
NCT04008563 Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium Status RECRUITING Phase NA
NCT04000880 Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health Status ACTIVE_NOT_RECRUITING Phase NA
NCT03983954 Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03955978 TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03935256 Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03932409 Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03926936 FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study Status COMPLETED Phase PHASE2
NCT03924466 Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients Status RECRUITING Phase PHASE2
NCT03908996 the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer Status COMPLETED Phase NA